Abstract
A 17-year-old Croatian boy with Nijmegen breakage syndrome (NBS) who developed diffuse large B-cell non-Hodgkin lymphoma is presented. The majority of the patients with this rare autosomal recessive disease are of Slavic origin and, in most of them, the disease is caused by NBS1 mutation 657del5, as was found in our patient. Nijmegen breakage syndrome is characterized by microcephaly, growth retardation, abnormal facial appearance, spontaneous chromosomal rearrangements, immunodeficiency, and a high predisposition to cancer development, predominantly lymphoma. Because of increased sensitivity to radiation therapy and chemotherapy, the treatment of malignancies in patients with NBS can be difficult. To our knowledge, our patient is the first with NBS reported in the literature who was successfully treated for diffuse large B-cell lymphoma with the anti-CD20 monoclonal antibody rituximab in addition to a modified dose of CHOP (cyclophosphamide/doxorubicin/vincristine/prednisone) chemotherapy. He has been in complete remission for 3 years after finishing the treatment.
References
Apr 1, 1985·American Journal of Medical Genetics·E SeemanováM Sevcíková
Jul 3, 1995·American Journal of Medical Genetics·K H ChrzanowskaG Lysón-Wojciechowska
Dec 1, 1994·International Journal of Radiation Biology·C M WeemaesC J van der Burgt
May 20, 1998·Cell·R VaronA Reis
Nov 26, 1999·Medical and Pediatric Oncology·K SeidemannA Reiter
May 9, 2000·Archives of Disease in Childhood
Nov 28, 2000·European Journal of Human Genetics : EJHG·R VaronA Reis
Mar 13, 2002·The EMBO Journal·Jian KangYang Xu
Jan 25, 2003·British Journal of Haematology·Gabriele RossiFranco Locatelli
Mar 7, 2003·Journal of Pediatric Hematology/oncology·Sameer BakhshiKanta Bhambhani
Oct 14, 2003·The Lancet Oncology·Sandro Vento, Francesca Cainelli
Jul 29, 2004·DNA Repair·Martin Digweed, Karl Sperling
Jun 21, 2005·Nature Cell Biology·Simone DifilippantonioAndré Nussenzweig
Aug 27, 2005·Pediatric Blood & Cancer·Gabriele KropshoferBernhard Meister
Aug 24, 2006·Expert Review of Anticancer Therapy·Gerhard HeldMichael Pfreundschuh
Citations
Mar 1, 2012·Orphanet Journal of Rare Diseases·Krystyna H ChrzanowskaMartin Digweed
May 1, 2010·Cellular and Molecular Life Sciences : CMLS·Laurence MeyerAyikoe Guy Mensah-Nyagan
Jan 31, 2016·European Journal of Medical Genetics·Agata PastorczakUNKNOWN International Berlin-Frankfurt-Munster (I-BFM) ALL host genetic variation working group
Jan 15, 2009·Pediatric Blood & Cancer·Shimrit ShabbatJoseph Kapelushnik
Oct 22, 2008·Pediatric Blood & Cancer·Bozenna Dembowska-BaginskaKrystyna H Chrzanowska
Feb 18, 2009·Journal of Hematology & Oncology·Ayad M Al-KatibRamzi M Mohammad
Mar 10, 2005·Leukemia Research·Jun MatsuiJunichiro Fujimoto
May 7, 2019·Frontiers in Immunology·Irbaz Bin RiazRoshini S Abraham
Jun 3, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michael F WalshSharon A Savage